Home › Funds › Knoll Capital Management, LLC › ALDX
Knoll Capital Management, LLC position in ALDX
ALDEYRA THERAPEUTICS INC · Health Care
Knoll Capital Management, LLC reported holding 5,475,516 shares of ALDX (ALDEYRA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$11.7M, representing 5.44% of its reported portfolio and ranking #4 among its reported holdings. Knoll Capital Management, LLC has disclosed ALDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Knoll Capital Management, LLC's ALDX position evolved
Knoll Capital Management, LLC first disclosed a stake in ALDX in Q3 2023 at 3,031,915 shares (US$20.3M). The position peaked in Q1 2025 at 5,475,516 shares, worth US$31.5M. Across 12 filings, Knoll Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 5,475,516 shares valued at US$11.7M. Notable position changes include a 81% increase in Q4 2023 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.03M | $20.25M | New |
| Q4 2023 | 5.48M | $19.22M | Add |
| Q1 2024 | 5.48M | $17.90M | Hold |
| Q2 2024 | 5.48M | $18.12M | Hold |
| Q3 2024 | 5.48M | $29.51M | Hold |
| Q4 2024 | 5.48M | $27.32M | Hold |
| Q1 2025 | 5.48M | $31.48M | Hold |
| Q2 2025 | 5.48M | $20.97M | Hold |
| Q3 2025 | 5.48M | $28.58M | Hold |
| Q4 2025 | 5.48M | $28.36M | Hold |
| Q1 2026 | 5.48M | $9.25M | Hold |
| Q2 2026 | 5.48M | $11.66M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALDX and 13F data
ALDX (ALDEYRA THERAPEUTICS INC) is a Health Care company. 21 other funds we track also report a position in ALDX. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Knoll Capital Management, LLC
FAQ
How long has Knoll Capital Management, LLC held ALDX?
Knoll Capital Management, LLC has disclosed ALDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Knoll Capital Management, LLC's current position in ALDX?
As of Q2 2026, Knoll Capital Management, LLC holds 5.48M shares of ALDX (ALDEYRA THERAPEUTICS INC), valued at $11.66M, representing 5.44% of its reported portfolio and ranking #4.
Has Knoll Capital Management, LLC been buying or selling ALDX?
In the latest 13F filing (Q2 2026), Knoll Capital Management, LLC held unchanged its position in ALDX. The position peaked in Q1 2025 at 5.48M shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.